Composition:
Duloxetine 20 mg, 30 mg and 60 mg delayed-release capsules containing enteric-coated pellets.

 Therapeutic indications:
Duloxeprin is indicated for the treatment of: 

     - Diabetic peripheral neuropathic pain in adults.  

     - Chronic musculoskeletal pain in adults.  

     - Fibromyalgia in adults and pediatric patients 13 years of age and older.

     - Major depressive disorder in adults.  

     - Generalized anxiety disorder in adults and pediatric patients 7 years of age and older.